
Senseonics Holdings (SENS) Stock Forecast & Price Target
Senseonics Holdings (SENS) Analyst Ratings
Bulls say
Senseonics Holdings Inc. demonstrates a positive financial outlook, with projected total revenues increasing from $59.7 million in 2025 to $75.6 million in 2026 and further rising to $118.4 million in 2027. Additionally, the company is experiencing significant growth, as evidenced by a 90% year-over-year increase in topline revenue during the first half of the year, alongside an improvement in gross margins from 36% in early 2025 to 43% in Q3. Management anticipates gross margins will exceed 50% by the end of 2026, partly due to a substantial 160% year-over-year increase in new patients adopting the Eversense 365 glucose monitoring system.
Bears say
Senseonics Holdings Inc. is projected to experience flat revenues in the first half of 2025, primarily due to the transition from previous U.S. distribution channels, indicating potential stagnation in growth opportunities. Despite reporting slightly higher total revenues of $8.1 million for the recent quarter compared to consensus estimates, the company continues to incur significant losses, with a net loss of $0.43 per share, which exceeds market expectations of a $0.40 loss. The reliance on international markets for revenue generation, combined with ongoing financial losses and flat growth projections, raises concerns regarding the company's ability to achieve sustainable profitability.
This aggregate rating is based on analysts' research of Senseonics Holdings and is not a guaranteed prediction by Public.com or investment advice.
Senseonics Holdings (SENS) Analyst Forecast & Price Prediction
Start investing in Senseonics Holdings (SENS)
Order type
Buy in
Order amount
Est. shares
0 shares